ACORN CAPITAL ADVISORS, LLC

Q2 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    21

  • Value ($000)

    $152,893

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0002054410
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CGON
CGON

CG ONCOLOGY INC

COM
156944100
$29.42M
19 %

1,131,501

---

UROGEN PHARMA LTD

COM
M96088105
$17.26M
11 %

1,259,749

YMAB
YMAB

Y-MABS THERAPEUTICS INC

COM
984241109
$15.42M
10 %

3,418,995

PBYI
PBYI

PUMA BIOTECHNOLOGY INC

COM
74587V107
$14.17M
9 %

4,131,299

CADL
CADL

CANDEL THERAPEUTICS INC

COM
137404109
$13.06M
9 %

2,580,517

---

TREVI THERAPEUTICS INC

COM
89532M101
$11.73M
8 %

2,144,844

TERN
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$7.35M
5 %

1,971,264

---

ONKURE THERAPEUTICS INC

CLASS A COM
68277Q105
$6.79M
4 %

2,839,674

---

CYBIN INC

COM NEW
23256X407
$6.16M
4 %

734,394

---

BICARA THERAPEUTICS

COM
055477103
$5.98M
4 %

643,382

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21